Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 59

1.

The chemokine system and CCR5 antagonists: potential in HIV treatment and other novel therapies.

Dhami H, Fritz CE, Gankin B, Pak SH, Yi W, Seya MJ, Raffa RB, Nagar S.

J Clin Pharm Ther. 2009 Apr;34(2):147-60. doi: 10.1111/j.1365-2710.2008.00978.x. Review.

PMID:
19250135
2.

Maraviroc, a CCR5 coreceptor antagonist that blocks entry of human immunodeficiency virus type 1.

Hunt JS, Romanelli F.

Pharmacotherapy. 2009 Mar;29(3):295-304. doi: 10.1592/phco.29.3.295. Review.

PMID:
19249948
3.

Evolution of CCR5 use before and during coreceptor switching.

Coetzer M, Nedellec R, Salkowitz J, McLaughlin S, Liu Y, Heath L, Mullins JI, Mosier DE.

J Virol. 2008 Dec;82(23):11758-66. doi: 10.1128/JVI.01141-08. Epub 2008 Sep 24.

4.

Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals.

Irlbeck DM, Amrine-Madsen H, Kitrinos KM, Labranche CC, Demarest JF.

AIDS. 2008 Jul 31;22(12):1425-31. doi: 10.1097/QAD.0b013e32830184ba.

PMID:
18614865
5.

Exceptional molecular and coreceptor-requirement properties of molecular clones isolated from an Human Immunodeficiency Virus Type-1 subtype C infection.

Dash PK, Siddappa NB, Mangaiarkarasi A, Mahendarkar AV, Roshan P, Anand KK, Mahadevan A, Satishchandra P, Shankar SK, Prasad VR, Ranga U.

Retrovirology. 2008 Mar 7;5:25. doi: 10.1186/1742-4690-5-25.

6.

Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing.

Salazar-Gonzalez JF, Bailes E, Pham KT, Salazar MG, Guffey MB, Keele BF, Derdeyn CA, Farmer P, Hunter E, Allen S, Manigart O, Mulenga J, Anderson JA, Swanstrom R, Haynes BF, Athreya GS, Korber BT, Sharp PM, Shaw GM, Hahn BH.

J Virol. 2008 Apr;82(8):3952-70. doi: 10.1128/JVI.02660-07. Epub 2008 Feb 6.

7.

Primary isolates of human immunodeficiency virus type 1 are usually dominated by the major variants found in blood.

Voronin Y, Chohan B, Emerman M, Overbaugh J.

J Virol. 2007 Oct;81(19):10232-41. Epub 2007 Jul 25.

8.

HIV-1 rational vaccine design: molecular details of b12-gp120 complex structure.

Phogat SK, Kaminsky SM, Koff WC.

Expert Rev Vaccines. 2007 Jun;6(3):319-21. No abstract available.

PMID:
17542747
9.

Longitudinal analysis of HIV type 1 subtype C envelope sequences from South Africa.

Coetzer M, Cilliers T, Papathanasopoulos M, Ramjee G, Karim SA, Williamson C, Morris L.

AIDS Res Hum Retroviruses. 2007 Feb;23(2):316-21.

PMID:
17331039
10.

Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004.

Hemelaar J, Gouws E, Ghys PD, Osmanov S.

AIDS. 2006 Oct 24;20(16):W13-23.

PMID:
17053344
11.

Novel envelope determinants for CCR3 use by human immunodeficiency virus.

Aasa-Chapman MM, Seymour CR, Williams I, McKnight A.

J Virol. 2006 Nov;80(21):10884-9.

12.

Genetic characteristics of the V3 region associated with CXCR4 usage in HIV-1 subtype C isolates.

Coetzer M, Cilliers T, Ping LH, Swanstrom R, Morris L.

Virology. 2006 Dec 5-20;356(1-2):95-105. Epub 2006 Aug 30.

13.

Circulating and unique recombinant forms of HIV type 1 containing subsubtype A2.

Visawapoka U, Tovanabutra S, Currier JR, Cox JH, Mason CJ, Wasunna M, Ponglikitmongkol M, Dowling WE, Robb ML, Birx DL, McCutchan FE.

AIDS Res Hum Retroviruses. 2006 Jul;22(7):695-702.

PMID:
16831094
14.

Genotypic and phenotypic characterization of viral isolates from HIV-1 subtype C-infected children with slow and rapid disease progression.

Choge I, Cilliers T, Walker P, Taylor N, Phoswa M, Meyers T, Viljoen J, Violari A, Gray G, Moore PL, Papathanosopoulos M, Morris L.

AIDS Res Hum Retroviruses. 2006 May;22(5):458-65.

PMID:
16706624
15.

A reliable phenotype predictor for human immunodeficiency virus type 1 subtype C based on envelope V3 sequences.

Jensen MA, Coetzer M, van 't Wout AB, Morris L, Mullins JI.

J Virol. 2006 May;80(10):4698-704.

16.

GP120: target for neutralizing HIV-1 antibodies.

Pantophlet R, Burton DR.

Annu Rev Immunol. 2006;24:739-69. Review.

PMID:
16551265
17.

HIV-1 subtype C in vitro growth and coreceptor utilization.

Ndung'u T, Sepako E, McLane MF, Chand F, Bedi K, Gaseitsiwe S, Doualla-Bell F, Peter T, Thior I, Moyo SM, Gilbert PB, Novitsky VA, Essex M.

Virology. 2006 Apr 10;347(2):247-60. Epub 2006 Jan 10.

18.

Neutralization escape variants of human immunodeficiency virus type 1 are transmitted from mother to infant.

Wu X, Parast AB, Richardson BA, Nduati R, John-Stewart G, Mbori-Ngacha D, Rainwater SM, Overbaugh J.

J Virol. 2006 Jan;80(2):835-44. Erratum in: J Virol. 2006 Mar;80(5):2585.

19.
20.

The global HIV vaccine enterprise.

Esparza J.

Int Microbiol. 2005 Jun;8(2):93-101. Review.

Supplemental Content

Support Center